Can Diphtheria Toxin be Used for Gene Therapy of Human Immunodeficiency Virus Infection?
- 1 December 1992
- journal article
- letter
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (12) , 1949-1950
- https://doi.org/10.1089/aid.1992.8.1949
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Intracellular Immunization:Trans-Dominant Mutants of HIV Gene Products as Tools for the Study and Interruption of Viral ReplicationAIDS Research and Human Retroviruses, 1992
- Cellular Transcription Factors Involved in the Regulation of HIV-1 Gene ExpressionAIDS, 1992
- Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population.Proceedings of the National Academy of Sciences, 1992
- Inhibition of HIV Production in Cells Containing an Integrated, HIV-Regulated Diphtheria Toxin A Chain GeneAIDS Research and Human Retroviruses, 1992
- Activation of a Diphtheria Toxin A Gene by Expression of Human Immunodeficiency Virus-1 Tat and Rev Proteins in Transfected CellsHuman Gene Therapy, 1991
- Regulation by HIV Rev depends upon recognition of splice sitesCell, 1989
- Targeting of an inducible toxic phenotype in animal cells.Proceedings of the National Academy of Sciences, 1988
- Intracellular immunizationNature, 1988
- TRANSMEMBRANE TRANSPORT OF DIPHTHERIA TOXIN, RELATED TOXINS, AND COLICINSAnnual Review of Biochemistry, 1986
- One molecule of diphtheria toxin fragment a introduced into a cell can kill the cellCell, 1978